title: Pheochromocytoma unmasked by amisulpride and tiapride.
abstract: OBJECTIVE
  To describe the unmasking of pheochromocytoma in a patient treated with amisulpride and tiapride.
  
  
  METHODS
  A 42-year-old white man developed acute hypertension with severe headache and vomiting 2 hours after the first doses of amisulpride 100 mg and tiapride 100 mg. Both drugs were immediately discontinued, and the patient recovered after subsequent nicardipine and verapamil treatment. Abdominal ultrasound showed an adrenal mass, and postoperative histologic examination confirmed the diagnosis of pheochromocytoma.
  
  
  CONCLUSIONS
  Drug-induced symptoms of pheochromocytoma are often associated with the use of substituted benzamide drugs, but the underlying mechanism is unknown. In our case, use of the Naranjo probability scale indicated a possible relationship between the hypertensive crisis and amisulpride and tiapride therapy.
  
  
  CONCLUSIONS
  As of March 24, 2005, this is the first reported case of amisulpride- and tiapride-induced hypertensive crisis in a patient with pheochromocytoma. Physicians and other healthcare professionals should be aware of this potential adverse effect of tiapride and amisulpride.
authors.affiliation: Pharmacy Department, Croix-Rousse Hospital, Lyon, France. agnes.henry@chu-lyon.fr
authors.forename: Agnès
authors.initials: A
authors.lastname: Henry
authors.forename: Bruno
authors.initials: B
authors.lastname: Charpiat
authors.forename: Thierry
authors.initials: T
authors.lastname: Vial
authors.forename: Serge
authors.initials: S
authors.lastname: Franchini
authors.forename: François J
authors.initials: FJ
authors.lastname: Cuilleret
authors.forename: Hugues
authors.initials: H
authors.lastname: Milon
mesh_terms: D000328:Adult; D000077582:Amisulpride; D014150:Antipsychotic Agents / Q000009:adverse effects*; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D006261:Headache / Q000139:chemically induced* / Q000150:complications / Q000188:drug therapy; D006801:Humans; D006973:Hypertension / Q000139:chemically induced* / Q000150:complications / Q000188:drug therapy; D008297:Male; D009529:Nicardipine / Q000627:therapeutic use; D010673:Pheochromocytoma / Q000175:diagnosis*; D013469:Sulpiride / Q000009:adverse effects / Q000031:analogs & derivatives*; D013976:Tiapamil Hydrochloride / Q000009:adverse effects*; D014700:Verapamil / Q000627:therapeutic use; D014839:Vomiting / Q000139:chemically induced* / Q000150:complications / Q000188:drug therapy
chemical_list: D014150:Antipsychotic Agents; D002121:Calcium Channel Blockers; D013469:Sulpiride; D000077582:Amisulpride; D014700:Verapamil; D009529:Nicardipine; D013976:Tiapamil Hydrochloride